Даниэль Шуваль

Научные публикации

• Infantile and Very Early Onset Inflammatory Bowel Disease: A Multicenter Study
• Clinical characteristics and outcomes of pediatric patients with autoimmune gastritis
• Different infliximab induction dosing regimens do not affect remission rates up to 1 year in children with Crohn's disease
• Sexual health in adolescents with inflammatory bowel disease - The paediatric gastroenterologists' point of view
• Tofacitinib in Pediatric Ulcerative Colitis: A Retrospective Multicenter Experience
• Familial Mediterranean fever in patients with inflammatory bowel diseases: A nationwide study from the epi-IIRN
• STEP-CD study: ustekinumab use in paediatric Crohn's disease-a multicentre retrospective study from paediatric IBD Porto group of ESPGHAN
• Longterm Outcome of Therapeutic Vaccination with a Third Generation Pre-S/S HBV Vaccine (PreHevbrio^R) of Chronically HBV Infected Patients
• A significant increase in anthropometric indices during long-term follow-up of pediatric patients with celiac disease, with no endocrine disorders
• Mucosal Genes Encoding Clock, Inflammation and Their Mutual Regulators Are Disrupted in Pediatric Patients with Active Ulcerative Colitis
• New-onset Blepharitis and Anti-TNF-Alpha Therapy in Patients with Crohn's Disease: A Case Series and Literature Review
• Adherence to the Mediterranean Diet Is Associated with Decreased Fecal Calprotectin Levels in Children with Crohn's Disease in Clinical Remission under Biological Therapy
• Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories
• Autoimmune amelogenesis imperfecta in patients with APS-1 and coeliac disease
• Precision medicine in monogenic inflammatory bowel disease: proposed mIBD REPORT standards
• Hepatitis A virus infection
• Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
• Thiopurines Maintenance Therapy in Children With Ulcerative Colitis: A Multicenter Retrospective Study
• Clinical Features and Natural History of Paediatric Patients with Ulcerative Proctitis: A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN
• A sound mind in a sound body: Stress-induced glucocorticoids exacerbate gut inflammation
• A tribute to Professor Peter Ferenci (1948-2023)
• Comparison of Clinical Outcomes in Pediatric Patients with Ileocolonic Crohn Disease Treated with Infliximab Versus Adalimumab
• Validation of predictive models for disease outcomes in paediatric ulcerative colitis: A multicentre prospective inception cohort
• Single-cell atlas of the human neonatal small intestine affected by necrotizing enterocolitis
• Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries
• Infantile-onset inflammatory bowel disease has variable long-term outcomes
• Immune dysregulation in Glycogen Storage Disease 1b - a CyTOF approach
• Correlation Between the Nancy Histopathology Index and Markers of Disease Activity in Pediatric Ulcerative Colitis
• Recurrence rates following ileo-colic resection in pediatric patients with Crohn's disease
• A somatic hypermutation-based machine learning model stratifies individuals with Crohn's disease and controls
• Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency
• RIPK1 mutations causing infantile-onset IBD with inflammatory and fistulizing features
• Incidence, Management, and Outcomes of Very Early Onset Inflammatory Bowel Diseases and Infantile-Onset Disease: An Epi-IIRN Study
• Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper
• Practice Variations in the Management of Infants With Non-IgE-Mediated Cow's Milk Protein Allergy
• Glycogen Storage Disease type IA refractory to cornstarch: Can next generation sequencing offer a solution?
• Mucosal healing with methotrexate versus azathioprine treatment in pediatric Crohn's disease as reflected by fecal calprotectin
• Mucus sialylation determines intestinal host-commensal homeostasis
• Host transcriptome signatures in human faecal-washes predict histological remission in patients with IBD
• Neonatal inflammatory skin and bowel disease type 1 caused by a complex genetic defect and responsive to combined anti-tumour necrosis factor-α and interleukin-12/23 blockade
• α4β7 expression guides B cells to front lines of defense in the gut
• Anti-SARS-CoV-2 antibodies elicited by COVID-19 mRNA vaccine exhibit a unique glycosylation pattern
• An Integrated Taxonomy for Monogenic Inflammatory Bowel Disease
• Clinical Features and Outcomes of Paediatric Patients With Isolated Colonic Crohn Disease
• Motivational disposition towards psychological characteristics of israeli children with inflammatory bowel diseases: A case-control study
• High anti-TNFα Concentrations Are Not Associated With More Adverse Events in Pediatric Inflammatory Bowel Disease
• CD16+CD163+ monocytes traffic to sites of inflammation during necrotizing enterocolitis in premature infants
• Monitoring Enables Progress: A Nationwide Quality Improvement Program in Children With Crohn Disease
• EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients
• T and B Cell Receptor Immune Repertoire Analysis using Next-generation Sequencing